Anti-factor D antibodies
US10179821B2 · kind B2 · utility
0Cited by
77References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2015 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Apr 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to anti-Factor D antibody variants, their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.